| 1 | The relationship between discharge location and cardiac rehabilitation use after cardiac surgery | 2.6 | 3 | Citations (PDF) |
| 2 | Interhospital variability in cardiac rehabilitation use after cardiac surgery among Medicare beneficiaries | 2.6 | 4 | Citations (PDF) |
| 3 | A gift of life, not immortality: Evaluation of a strategy of heart transplant listing in the older patient with advanced heart failure | 1.1 | 7 | Citations (PDF) |
| 4 | Pump exchange for major device related infection in patients receiving a durable left ventricular assist device | 1.1 | 1 | Citations (PDF) |
| 5 | The Society of Thoracic Surgeons National Intermacs Database Risk Model for Durable Left Ventricular Assist Device Implantation | 2.3 | 5 | Citations (PDF) |
| 6 | The Important and Untapped Role of the Surgeon in Cardiac Rehabilitation | 0.2 | 0 | Citations (PDF) |
| 7 | Design and rationale for the clinical investigation of a novel, magnetically levitated left ventricular assist device for the treatment of refractory heart failure | 1.1 | 7 | Citations (PDF) |
| 8 | Consensus on Key Attributes of Cardiac Surgeons’ Intraoperative Performance | 1.9 | 0 | Citations (PDF) |
| 9 | Heterogeneity in HeartMate 3 implanting center infection management reveals opportunities for quality improvement and best practice initiatives during left ventricular assist device support | 1.1 | 4 | Citations (PDF) |
| 10 | Selection of complications to define failure to rescue as an optimal quality improvement metric | 2.6 | 4 | Citations (PDF) |
| 11 | Skilled Nursing Facility Quality Rating and Surgical Outcomes Following Coronary Artery Bypass Grafting | 1.6 | 4 | Citations (PDF) |
| 12 | In search of similarity in adverse events journeys of patients with left ventricular assist devices | 2.6 | 0 | Citations (PDF) |
| 13 | The association of intraoperative and early postoperative events with risk of pneumonia following cardiac surgery | 2.6 | 16 | Citations (PDF) |
| 14 | Gastrointestinal bleeding following Heartmate 3 left ventricular assist device implantation: The Michigan Bleeding Risk Model | 1.1 | 8 | Citations (PDF) |
| 15 | Hospital Variation in Skilled Nursing Facility Use After Coronary Artery Bypass Graft Surgery | 4.0 | 2 | Citations (PDF) |
| 16 | Determinants of survival following heart transplantation in adults with congenital heart disease | 1.3 | 9 | Citations (PDF) |
| 17 | Safety and hemodynamic implications of transseptal access for ventricular tachycardia ablation in patients with left ventricular assist devices | 1.9 | 1 | Citations (PDF) |
| 18 | THE USAGE OF AORTIC ANNULAR ENLARGEMENT AFTER INTRODUCTION OF THE Y-INCISION TECHNIQUE | 2.3 | 0 | Citations (PDF) |
| 19 | Home Health Care Use and Outcomes After Coronary Artery Bypass Grafting Among Medicare Beneficiaries | 4.1 | 4 | Citations (PDF) |
| 20 | Outcomes of nonemergency cardiac surgery after overnight operative workload: A statewide experience | 1.2 | 0 | Citations (PDF) |
| 21 | Extrinsic outflow graft obstruction of the HeartMate 3 LVAD: A state-of-the-art review | 1.1 | 20 | Citations (PDF) |
| 22 | Disparities in Skilled Nursing Facility Use and Outcomes After Cardiac Surgery | 1.6 | 1 | Citations (PDF) |
| 23 | Multicenter Analysis of the Relationship Between Operative Team Familiarity and Safety and Efficiency Outcomes in Cardiac Surgery | 4.1 | 3 | Citations (PDF) |
| 24 | Mitral regurgitation severity at left ventricular assist device implantation is associated with distinct myocardial transcriptomic signatures | 2.6 | 6 | Citations (PDF) |
| 25 | Failure to rescue: A candidate quality metric for durable left ventricular assist device implantation | 2.6 | 8 | Citations (PDF) |
| 26 | Mortality following durable left ventricular assist device implantation by timing and type of first infection | 2.6 | 15 | Citations (PDF) |
| 27 | A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19 | 8.9 | 73 | Citations (PDF) |
| 28 | Coronary Artery Bypass Surgery Among Medicare Beneficiaries in Health Professional Shortage Areas | 4.6 | 3 | Citations (PDF) |
| 29 | Metabolic reprogramming by immune-responsive gene 1 up-regulation improves donor heart preservation and function | 12.5 | 43 | Citations (PDF) |
| 30 | Translation of immunomodulatory therapy to treat chronic heart failure: Preclinical studies to first in human | 2.3 | 11 | Citations (PDF) |
| 31 | Use of a Pulmonary Artery Pressure Sensor to Manage Patients With Left Ventricular Assist Devices | 4.4 | 29 | Citations (PDF) |
| 32 | Change in Caregiver Health-Related Quality of Life From Before to Early After Surgery: SUSTAIN-IT Study | 4.4 | 2 | Citations (PDF) |
| 33 | Cardiac Rehabilitation Reduces 2-Year Mortality After Coronary Artery Bypass Grafting | 2.3 | 23 | Citations (PDF) |
| 34 | Intermacs quarterly report analysis to monitor longitudinal outcomes in a centrifugal flow assist device | 1.1 | 3 | Citations (PDF) |
| 35 | Interhospital variability in failure to rescue rates following aortic valve surgery | 1.2 | 1 | Citations (PDF) |
| 36 | Lessons learned from the EACTS-MSTCVS quality fellowship: a call to action for continuous improvement of cardiothoracic surgery outcomes in Europe | 1.4 | 5 | Citations (PDF) |
| 37 | Determinants and Outcomes Associated With Skilled Nursing Facility Use After Coronary Artery Bypass Grafting: A Statewide Experience | 4.1 | 2 | Citations (PDF) |
| 38 | Durable Mechanical Circulatory Support | 2.3 | 56 | Citations (PDF) |
| 39 | Relationship Between Community-Level Distress and Cardiac Rehabilitation Participation, Facility Access, and Clinical Outcomes After Inpatient Coronary Revascularization | 4.1 | 5 | Citations (PDF) |
| 40 | Impact of donor blood type on outcomes after prolonged allograft ischemic times | 2.6 | 4 | Citations (PDF) |
| 41 | Interhospital variability in health care–associated infections and payments after durable ventricular assist device implant among Medicare beneficiaries | 2.6 | 17 | Citations (PDF) |
| 42 | Concordance of Treatment Effect: An Analysis of The Society of Thoracic Surgeons Intermacs Database | 2.3 | 38 | Citations (PDF) |
| 43 | Long-term survival on LVAD support: Device complications and end-organ dysfunction limit long-term success | 1.1 | 56 | Citations (PDF) |
| 44 | A challenge to equity in transplantation: Increased center-level variation in short-term mechanical circulatory support use in the context of the updated U.S. heart transplant allocation policy | 1.1 | 27 | Citations (PDF) |
| 45 | Time in Therapeutic Range Significantly Impacts Survival and Adverse Events in Destination Therapy Patients | 1.8 | 12 | Citations (PDF) |
| 46 | Generalizability of Trial Data to Real-World Practice: An Analysis of The Society of Thoracic Surgeons Intermacs Database | 2.3 | 7 | Citations (PDF) |
| 47 | HVAD to Heartmate 3 Device Exchange: A Society of Thoracic Surgeons Intermacs Analysis | 2.3 | 26 | Citations (PDF) |
| 48 | Non-patient factors associated with infections in LVAD recipients: A scoping review | 1.1 | 13 | Citations (PDF) |
| 49 | Strategies for Mechanical Right Ventricular Support During Left Ventricular Assist Device Implant | 2.3 | 13 | Citations (PDF) |
| 50 | Ultrasonic Emulsification of Severe Mitral Annular Calcification During Mitral Valve Replacement | 2.3 | 21 | Citations (PDF) |
| 51 | Twelfth Interagency Registry for Mechanically Assisted Circulatory Support Report: Readmissions After Left Ventricular Assist Device | 2.3 | 154 | Citations (PDF) |
| 52 | Impact of preoperative versus postoperative dialysis on left ventricular assist device outcomes: An analysis from the Society of Thoracic Surgeons Interagency Registry for Mechanically Assisted Circulatory Support database | 1.2 | 5 | Citations (PDF) |
| 53 | Graft Resistance Difference after HVAD to HeartMate 3 Left Ventricular Assist Device Exchange | 2.3 | 10 | Citations (PDF) |
| 54 | Patient factors associated with left ventricular assist device infections: A scoping review | 1.1 | 20 | Citations (PDF) |
| 55 | Health‐Related Quality of Life in Older Patients With Advanced Heart Failure: Findings From the SUSTAIN‐IT Study | 4.0 | 12 | Citations (PDF) |
| 56 | Advancing Quality Metrics for Durable Left Ventricular Assist Device Implant: Analysis of the Society of Thoracic Surgeons Intermacs Database | 2.3 | 15 | Citations (PDF) |
| 57 | HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations | 2.6 | 19 | Citations (PDF) |
| 58 | Outcomes With Phosphodiesterase-5 Inhibitor Use After Left Ventricular Assist Device: An STS-INTERMACS Analysis | 4.4 | 11 | Citations (PDF) |
| 59 | HVAD to HeartMate 3 Left Ventricular Assist Device Exchange: Best Practices Recommendations | 2.3 | 12 | Citations (PDF) |
| 60 | Association between biventricular pacing and incidence of ventricular arrhythmias in the early post‐operative period after left ventricular assist device implantation | 2.1 | 9 | Citations (PDF) |
| 61 | HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations | 1.4 | 6 | Citations (PDF) |
| 62 | The role of surgery for secondary mitral regurgitation and heart failure in the era of transcatheter mitral valve therapies | 1.1 | 15 | Citations (PDF) |
| 63 | Rescuing the right ventricle: A conceptual framework to target new interventions for patients receiving a durable left ventricular assist device | 2.6 | 4 | Citations (PDF) |
| 64 | Quality of life metrics in LVAD patients after hemocompatibility‐related adverse events | 1.8 | 4 | Citations (PDF) |
| 65 | Center Variability in Patient Outcomes Following HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial | 1.8 | 24 | Citations (PDF) |
| 66 | Determining optimal donor heart ischemic times in adult cardiac transplantation | 0.9 | 17 | Citations (PDF) |
| 67 | Global best practices consensus: Long-term management of patients with hybrid centrifugal flow left ventricular assist device support | 2.6 | 16 | Citations (PDF) |
| 68 | Variation in Cardiac Rehabilitation Participation During Aortic Valve Replacement Episodes of Care | 4.1 | 17 | Citations (PDF) |
| 69 | Defects in the Proteome and Metabolome in Human Hypertrophic Cardiomyopathy | 4.4 | 89 | Citations (PDF) |
| 70 | Incompleteness of health-related quality of life assessments before left ventricular assist device implant: A novel quality metric | 1.1 | 7 | Citations (PDF) |
| 71 | Association Between Care Fragmentation and Total Spending After Durable Left Ventricular Device Implant: A Mediation Analysis of Health Care–Associated Infections Within a National Medicare-Society of Thoracic Surgeons Intermacs Linked Dataset | 4.1 | 5 | Citations (PDF) |
| 72 | Identifying potential candidates for advanced heart failure therapies using an interpretable machine learning algorithm | 1.1 | 9 | Citations (PDF) |
| 73 | Sex-based considerations for implementation of ventricular assist device therapy | 2.4 | 2 | Citations (PDF) |
| 74 | Transcatheter Aortic Valve Replacement for Left Ventricular Assist Device–Related Aortic Regurgitation: The Michigan Medicine Experience | 0.7 | 6 | Citations (PDF) |
| 75 | Non-invasive estimation of relative pressure for intracardiac flows using virtual work-energy | 10.6 | 22 | Citations (PDF) |
| 76 | Durable mechanical circulatory support device use in the United States by geographic region and minority status | 2.6 | 8 | Citations (PDF) |
| 77 | Assessment of Mortality Among Durable Left Ventricular Assist Device Recipients Ineligible for Clinical Trials | 6.6 | 15 | Citations (PDF) |
| 78 | Fate of preoperative moderate mitral regurgitation following left ventricular assist device implantation | 0.9 | 4 | Citations (PDF) |
| 79 | Left Ventricular Assist Device Implantation in Patients with Preoperative Severe Mitral Regurgitation | 1.8 | 5 | Citations (PDF) |
| 80 | The Society of Thoracic Surgeons Intermacs 2020 Annual Report | 2.3 | 550 | Citations (PDF) |
| 81 | The Impact of Adverse Events on Functional Capacity and Quality of Life After HeartWare Ventricular Assist Device Implantation | 1.8 | 1 | Citations (PDF) |
| 82 | Clinical outcomes and healthcare expenditures in the real world with left ventricular assist devices – The CLEAR-LVAD study | 1.1 | 39 | Citations (PDF) |
| 83 | Risk factors for heart transplant survival with greater than 5 h of donor heart ischemic time | 0.9 | 15 | Citations (PDF) |
| 84 | Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo‐controlled, non‐inferiority ARIES HM3 trial | 7.3 | 67 | Citations (PDF) |
| 85 | Rates and types of infections in left ventricular assist device recipients: A scoping review | 1.2 | 15 | Citations (PDF) |
| 86 | Differential inflammatory responses of the native left and right ventricle associated with donor heart preservation | 1.6 | 6 | Citations (PDF) |
| 87 | Reduced Echocardiographic Inotropy Index after Cardiopulmonary Bypass Is Associated With Complications After Cardiac Surgery: An Institutional Outcomes Study | 1.4 | 2 | Citations (PDF) |
| 88 | Impact of thoracotomy approach on right ventricular failure and length of stay in left ventricular assist device implants: an intermacs registry analysis | 1.1 | 23 | Citations (PDF) |
| 89 | Long-Term Neurocognitive Outcome in Patients With Continuous Flow Left Ventricular Assist Device | 4.4 | 6 | Citations (PDF) |
| 90 | The impact of team familiarity on intra and postoperative cardiac surgical outcomes | 1.8 | 22 | Citations (PDF) |
| 91 | Center Variability in Medicare Claims–Based Publicly Reported Transcatheter Aortic Valve Replacement Outcome Measures | 4.0 | 2 | Citations (PDF) |
| 92 | 346: Reducing New-Onset Postoperative Atrial Fibrillation After Isolated Coronary Artery Bypass Surgery | 0.5 | 0 | Citations (PDF) |
| 93 | Evolution of Late Right Heart Failure With Left Ventricular Assist Devices and Association With Outcomes | 2.3 | 81 | Citations (PDF) |
| 94 | Right ventricular function and residual mitral regurgitation after left ventricular assist device implantation determines the incidence of right heart failure | 2.6 | 28 | Citations (PDF) |
| 95 | Diagnostic Accuracy of FDG PET/CT in Suspected LVAD Infections | 6.1 | 76 | Citations (PDF) |
| 96 | Early Structural Valve Degeneration of Trifecta Bioprosthesis | 2.3 | 82 | Citations (PDF) |
| 97 | Outcomes based on blood pressure in patients on continuous flow left ventricular assist device support: An Interagency Registry for Mechanically Assisted Circulatory Support analysis | 1.1 | 28 | Citations (PDF) |
| 98 | Registry Evaluation of Vital Information for VADs in Ambulatory Life (REVIVAL): Rationale, design, baseline characteristics, and inclusion criteria performance | 1.1 | 19 | Citations (PDF) |
| 99 | Continuous-Flow Left Ventricular Assist Devices and Valvular Heart Disease: A Comprehensive Review | 2.6 | 36 | Citations (PDF) |
| 100 | An early investigation of outcomes with the new 2018 donor heart allocation system in the United States | 1.1 | 284 | Citations (PDF) |
| 101 | Histidine-Tryptophan-Ketoglutarate Solution for Donor Heart Preservation Is Safe for Transplantation | 2.3 | 11 | Citations (PDF) |
| 102 | Sources of Hospital Variation in Postacute Care Spending After Cardiac Surgery | 4.1 | 21 | Citations (PDF) |
| 103 | Classification of the Frequency, Severity, and Propagation of Thrombi in the HeartMate II Left Ventricular Assist Device | 1.8 | 12 | Citations (PDF) |
| 104 | Strategies of Wait-listing for Heart Transplant vs Durable Mechanical Circulatory Support Alone for Patients With Advanced Heart Failure | 11.1 | 33 | Citations (PDF) |
| 105 | Quantifying the impact from stroke during support with continuous flow ventricular assist devices: An STS INTERMACS analysis | 1.1 | 28 | Citations (PDF) |
| 106 | Updated definitions of adverse events for trials and registries of mechanical circulatory support: A consensus statement of the mechanical circulatory support academic research consortium | 1.1 | 207 | Citations (PDF) |
| 107 | Aortic Valve Repair Versus Replacement Associated With Durable Left Ventricular Assist Devices | 2.3 | 11 | Citations (PDF) |
| 108 | Understanding risk factors and predictors for stroke subtypes in the ENDURANCE trials | 1.1 | 18 | Citations (PDF) |
| 109 | The Society of Thoracic Surgeons Intermacs 2019 Annual Report: The Changing Landscape of Devices and Indications | 2.3 | 390 | Citations (PDF) |
| 110 | Right Heart Failure After Left Ventricular Assist Device Placement | 1.5 | 25 | Citations (PDF) |
| 111 | Access to Transcatheter Aortic Valve Replacement Under New Medicare Surgical Volume Requirements | 11.1 | 11 | Citations (PDF) |
| 112 | Identifying Temporal Relationships Between In‐Hospital Adverse Events After Implantation of Durable Left Ventricular Assist Devices | 4.0 | 14 | Citations (PDF) |
| 113 | Guidelines for the Use of Transesophageal Echocardiography to Assist with Surgical Decision-Making in the Operating Room: A Surgery-Based Approach | 3.4 | 244 | Citations (PDF) |
| 114 | Ventricular Assist Device Driveline Dressing-Change Protocols: A Need for Standardization. A Report from the SimVAD Investigators | 1.8 | 10 | Citations (PDF) |
| 115 | The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships | 2.3 | 194 | Citations (PDF) |
| 116 | Center Variation in Medicare Spending for Durable Left Ventricular Assist Device Implant Hospitalizations | 11.1 | 16 | Citations (PDF) |
| 117 | The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships | 1.1 | 388 | Citations (PDF) |
| 118 | Long-Term Survival and Echocardiographic Findings After Surgical Ventricular Restoration | 2.3 | 10 | Citations (PDF) |
| 119 | Preimplant Phosphodiesterase-5 Inhibitor Use Is Associated With Higher Rates of Severe Early Right Heart Failure After Left Ventricular Assist Device Implantation | 4.4 | 49 | Citations (PDF) |
| 120 | Right ventricular failure following left ventricular assist device implantation is associated with a preoperative pro-inflammatory response | 1.3 | 18 | Citations (PDF) |
| 121 | A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report | 34.5 | 1,202 | Citations (PDF) |
| 122 | Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure | 16.5 | 112 | Citations (PDF) |
| 123 | High Transpulmonary Artery Gradient Obtained at the Time of Left Ventricular Assist Device Implantation Negatively Affects Survival After Cardiac Transplantation | 1.8 | 7 | Citations (PDF) |
| 124 | Device Therapy and Arrhythmia Management in Left Ventricular Assist Device Recipients: A Scientific Statement From the American Heart Association | 18.0 | 152 | Citations (PDF) |
| 125 | Stroke and death risk in ventricular assist device patients varies by ISHLT infection category: An INTERMACS analysis | 1.1 | 46 | Citations (PDF) |
| 126 | Cluster analysis of preoperative echocardiographic findings and outcomes following left ventricular device implantation | 2.6 | 8 | Citations (PDF) |
| 127 | Cardiac contractile dysfunction and protein kinase C–mediated myofilament phosphorylation in disease and aging | 2.4 | 15 | Citations (PDF) |
| 128 | A novel, highly discriminatory risk model predicting acute severe right ventricular failure in patients undergoing continuous‐flow left ventricular assist device implant | 1.8 | 14 | Citations (PDF) |
| 129 | Impact of Patient Distance From Ventricular Assist Device–Implanting Center on Short- and Long-Term Outcomes | 1.8 | 8 | Citations (PDF) |
| 130 | Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association | 18.0 | 834 | Citations (PDF) |
| 131 | Association of Donor Tricuspid Valve Repair With Outcomes After Cardiac Transplantation | 2.3 | 11 | Citations (PDF) |
| 132 | Linkage of Medicare Records to the Interagency Registry of Mechanically Assisted Circulatory Support | 2.3 | 17 | Citations (PDF) |
| 133 | Deactivation without explantation of a durable left ventricular assist device: A durable solution? | 2.6 | 1 | Citations (PDF) |
| 134 | Mechanical Circulatory Support for the Failing Fontan: Conversion to Assisted Single Ventricle Circulation—Preliminary Observations | 0.8 | 8 | Citations (PDF) |
| 135 | Advancing the Science of Self‐Management in Adults With Long‐Term Left Ventricular Assist Devices | 1.8 | 16 | Citations (PDF) |
| 136 | Adverse Effects of Delayed Transplant Listing Among Patients With Implantable Left Ventricular Assist Devices | 1.8 | 2 | Citations (PDF) |
| 137 | Development and Feasibility of Self-Management Application in Left-Ventricular Assist Devices | 1.8 | 26 | Citations (PDF) |
| 138 | Left Lateral Thoracotomy for Centrifugal Continuous-Flow Left Ventricular Assist Device Placement: An Analysis from the Mechanical Circulatory Support Research Network | 1.8 | 66 | Citations (PDF) |
| 139 | Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial | 1.1 | 40 | Citations (PDF) |
| 140 | Repeated, Close Physician Coronary Artery Bypass Grafting Teams Associated with Greater Teamwork | 2.1 | 25 | Citations (PDF) |
| 141 | 2152. Epidemiology and Clinical Outcomes of Contemporary, Third-Generation Left Ventricular Assist Device (LVAD) Infections | 0.8 | 0 | Citations (PDF) |
| 142 | Continuous-Flow Device Engineering and Pump Technology | 1.5 | 8 | Citations (PDF) |
| 143 | Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study | 18.0 | 70 | Citations (PDF) |
| 144 | HVAD: The ENDURANCE Supplemental Trial | 4.4 | 212 | Citations (PDF) |
| 145 | Sleep and self-care correlates before and after implantation of a left-ventricular assist device (LVAD) | 1.1 | 9 | Citations (PDF) |
| 146 | Left ventricular assist device outcomes based on flow configuration and pre-operative left ventricular dimension: An Interagency Registry for Mechanically Assisted Circulatory Support Analysis | 1.1 | 39 | Citations (PDF) |
| 147 | Correlation of Pre-Explant Lactate Dehydrogenase Concentrations and Findings During Post-Explant Pump Analysis of the HeartMate II Left Ventricular Assist Device | 2.3 | 4 | Citations (PDF) |
| 148 | Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure | 34.5 | 717 | Citations (PDF) |
| 149 | Implantation of a Durable Left Ventricular Assist Device: How I Teach It | 2.3 | 9 | Citations (PDF) |
| 150 | Advancing the Science of Myocardial Recovery With Mechanical Circulatory Support: A Working Group of the National, Heart, Lung and Blood Institute | 1.8 | 11 | Citations (PDF) |
| 151 | Recommendations for the Use of Mechanical Circulatory Support: Ambulatory and Community Patient Care: A Scientific Statement From the American Heart Association | 18.0 | 93 | Citations (PDF) |
| 152 | Pump thrombosis: Do we have the answer to the riddle? | 2.6 | 0 | Citations (PDF) |
| 153 | Advancing the science of myocardial recovery with mechanical circulatory support: A Working Group of the National, Heart, Lung, and Blood Institute | 2.6 | 10 | Citations (PDF) |
| 154 | Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation | 4.4 | 108 | Citations (PDF) |
| 155 | Impact of Center Left Ventricular Assist Device Volume on Outcomes After Implantation | 4.4 | 63 | Citations (PDF) |
| 156 | Eighth annual INTERMACS report: Special focus on framing the impact of adverse events | 1.1 | 1,169 | Citations (PDF) |
| 157 | Advancing the Science of Myocardial Recovery With Mechanical Circulatory Support | 3.3 | 41 | Citations (PDF) |
| 158 | Temporal Differences in Outcomes During Long-Term Mechanical Circulatory Support | 1.8 | 4 | Citations (PDF) |
| 159 | Percutaneous Driveline Fracture After Implantation of the HeartMate II Left Ventricular Assist Device: How Durable is Driveline Repair? | 1.8 | 13 | Citations (PDF) |
| 160 | Advancing the Science of Myocardial Recovery with Mechanical Circulatory Support: A Working Group of the National, Heart, Lung, and Blood Institute | 1.8 | 4 | Citations (PDF) |
| 161 | A multi-institutional outcome analysis of patients undergoing left ventricular assist device implantation stratified by sex and race | 1.1 | 47 | Citations (PDF) |
| 162 | Outcomes of Patients Receiving Temporary Circulatory Support Before Durable Ventricular Assist Device | 2.3 | 50 | Citations (PDF) |
| 163 | A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure | 34.5 | 719 | Citations (PDF) |
| 164 | Complications, Risk Factors, and Staffing Patterns for Noncardiac Surgery in Patients with Left Ventricular Assist Devices | 2.2 | 45 | Citations (PDF) |
| 165 | Clinical Outcomes of Advanced Heart Failure Patients with Cardiogenic Shock Treated with Temporary Circulatory Support Before Durable LVAD Implant | 1.8 | 36 | Citations (PDF) |
| 166 | Differential protein expression and basal lamina remodeling in human heart failure | 2.2 | 46 | Citations (PDF) |
| 167 | Outcomes After Concomitant Procedures with Left Ventricular Assist Device Implantation: Implications by Device Type and Indication | 1.8 | 12 | Citations (PDF) |
| 168 | Reduce Driveline Trauma Through Stabilization and Exit Site Management: 30 Days Feasibility Results from the Multicenter RESIST Study | 1.8 | 21 | Citations (PDF) |
| 169 | Comparing the Effectiveness of an Axial and a Centrifugal Left Ventricular Assist Device in Ventricular Unloading | 1.8 | 12 | Citations (PDF) |
| 170 | Association Between Physician Teamwork and Health System Outcomes After Coronary Artery Bypass Grafting | 4.1 | 43 | Citations (PDF) |
| 171 | Genotype-Dependent and -Independent Calcium Signaling Dysregulation in Human Hypertrophic Cardiomyopathy | 18.0 | 92 | Citations (PDF) |
| 172 | Ventricular Assist Device Therapy in Older Patients With Heart Failure: Characteristics and Outcomes | 1.8 | 34 | Citations (PDF) |
| 173 | Patients Awaiting Heart Transplantation on HVAD Support for Greater Than 2 Years | 1.8 | 12 | Citations (PDF) |
| 174 | Use of the total artificial heart as a bridge to transplant in a 13-year-old with congenitally corrected transposition of the great arteries | 2.6 | 7 | Citations (PDF) |
| 175 | INTERMACS profiles and modifiers: Heterogeneity of patient classification and the impact of modifiers on predicting patient outcome | 1.1 | 68 | Citations (PDF) |
| 176 | Age and gender differences and factors related to change in health-related quality of life from before to 6 months after left ventricular assist device implantation: Findings from Interagency Registry for Mechanically Assisted Circulatory Support | 1.1 | 73 | Citations (PDF) |
| 177 | Adverse event burden and mechanical circulatory support: Looking toward the future | 2.6 | 11 | Citations (PDF) |
| 178 | Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences | 2.6 | 130 | Citations (PDF) |
| 179 | Temporal Differences in Causes of Mortality After Left Ventricular Assist Device Implantation | 2.3 | 14 | Citations (PDF) |
| 180 | Treatment of device thrombus in the HeartWare HVAD: Success and outcomes depend significantly on the initial treatment strategy | 1.1 | 54 | Citations (PDF) |
| 181 | Pump thrombosis in the Thoratec HeartMate II device: An update analysis of the INTERMACS Registry | 1.1 | 177 | Citations (PDF) |
| 182 | Too much of a good thing? Reducing cannula size and flow rates during extracorporeal life support | 2.6 | 2 | Citations (PDF) |
| 183 | Concomitant aortic valve procedures in patients undergoing implantation of continuous-flow left ventricular assist devices: An INTERMACS database analysis | 1.1 | 91 | Citations (PDF) |
| 184 | Uncorrected pre-operative mitral valve regurgitation is not associated with adverse outcomes after continuous-flow left ventricular assist device implantation | 1.1 | 65 | Citations (PDF) |
| 185 | Risk Factors Related to Transfusion Requirements in Patients Undergoing Implantation of Ventricular Assist Devices | 1.4 | 1 | Citations (PDF) |
| 186 | An examination of survival by sex and race in the HeartWare Ventricular Assist Device for the Treatment of Advanced Heart Failure (ADVANCE) Bridge to Transplant (BTT) and continued access protocol trials | 1.1 | 42 | Citations (PDF) |
| 187 | A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy | 1.1 | 69 | Citations (PDF) |
| 188 | Seventh INTERMACS annual report: 15,000 patients and counting | 1.1 | 1,298 | Citations (PDF) |
| 189 | The HVAD Left Ventricular Assist Device | 4.4 | 182 | Citations (PDF) |
| 190 | Identification and Management of Pump Thrombus in the HeartWare Left Ventricular Assist Device System | 4.4 | 77 | Citations (PDF) |
| 191 | The quest toward the Holy Grail of mechanical circulatory support | 2.6 | 2 | Citations (PDF) |
| 192 | Impact of Left Ventricular Assist Device on Diabetes Management: An Evaluation through Case Analysis and Clinical Impact | 1.0 | 3 | Citations (PDF) |
| 193 | Clinical Outcomes After Implantation of a Centrifugal Flow Left Ventricular Assist Device and Concurrent Cardiac Valve Procedures | 18.0 | 36 | Citations (PDF) |
| 194 | Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device | 1.1 | 145 | Citations (PDF) |
| 195 | Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support | 1.1 | 121 | Citations (PDF) |
| 196 | Outcomes After Transfer to a Tertiary Center for Postcardiotomy Cardiopulmonary Failure | 2.3 | 5 | Citations (PDF) |
| 197 | Overall quality of life improves to similar levels after mechanical circulatory support regardless of severity of heart failure before implantation | 1.1 | 81 | Citations (PDF) |
| 198 | Sarcomere Mutation-Specific Expression Patterns in Human Hypertrophic Cardiomyopathy | 3.8 | 100 | Citations (PDF) |
| 199 | Consequences of aortic insufficiency during long-term axial continuous-flow left ventricular assist device support | 1.1 | 82 | Citations (PDF) |
| 200 | “Prophylactic” Tricuspid Repair for Functional Tricuspid Regurgitation | 2.3 | 30 | Citations (PDF) |
| 201 | An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial | 1.1 | 458 | Citations (PDF) |
| 202 | Hemolysis: A harbinger of adverse outcome after left ventricular assist device implant | 1.1 | 151 | Citations (PDF) |
| 203 | Sixth INTERMACS annual report: A 10,000-patient database | 1.1 | 795 | Citations (PDF) |
| 204 | Family Caregivers' inside Perspectives: Caring for an Adult with a Left Ventricular Assist Device as a Destination Therapy | 0.9 | 31 | Citations (PDF) |
| 205 | The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: Executive summary | 1.1 | 1,331 | Citations (PDF) |
| 206 | Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients | 1.1 | 693 | Citations (PDF) |
| 207 | Pump Replacement for Left Ventricular Assist Device Failure Can Be Done Safely and Is Associated With Low Mortality | 2.3 | 118 | Citations (PDF) |
| 208 | Quantifying the effect of cardiorenal syndrome on mortality after left ventricular assist device implant | 1.1 | 115 | Citations (PDF) |
| 209 | Predicting Survival in Patients Receiving Continuous Flow Left Ventricular Assist Devices | 2.3 | 318 | Citations (PDF) |
| 210 | Certification for Implantation of Durable, Implantable Ventricular Assist Devices in the United States: The Need for Clarification of the Process | 2.3 | 2 | Citations (PDF) |
| 211 | Device Exchange After Primary Left Ventricular Assist Device Implantation: Indications and Outcomes | 2.3 | 80 | Citations (PDF) |
| 212 | Preoperative Atrial Fibrillation Increases Risk of Thromboembolic Events After Left Ventricular Assist Device Implantation | 2.3 | 87 | Citations (PDF) |
| 213 | HeartWare HVAD: Principles and Techniques for Implantation | 0.4 | 5 | Citations (PDF) |
| 214 | Impact of Coronary CT Angiography on Surgical Decision-Making for Coronary Artery Bypass Graft Surgery | 2.7 | 5 | Citations (PDF) |
| 215 | Prospective, Multicenter Study of Ventricular Assist Device Infections | 18.0 | 255 | Citations (PDF) |
| 216 | Statement Regarding the Pre and Post Market Assessment of Durable, Implantable Ventricular Assist Devices in the United States | 4.4 | 7 | Citations (PDF) |
| 217 | Statement Regarding the Pre and Post Market Assessment of Durable, Implantable Ventricular Assist Devices in the United States: Executive Summary | 4.4 | 3 | Citations (PDF) |
| 218 | Prevention of Percutaneous Driveline Infection After Left Ventricular Assist Device Implantation | 1.8 | 38 | Citations (PDF) |
| 219 | CTLA4-Ig | 6.2 | 0 | Citations (PDF) |
| 220 | Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation | 18.0 | 638 | Citations (PDF) |
| 221 | Recommendations for the Use of Mechanical Circulatory Support: Device Strategies and Patient Selection | 18.0 | 313 | Citations (PDF) |
| 222 | Beating heart surgery via right thoracotomy for reoperative mitral valve surgery: A safe and effective operative alternative | 2.6 | 55 | Citations (PDF) |
| 223 | Long-term mechanical circulatory support (destination therapy): On track to compete with heart transplantation? | 2.6 | 239 | Citations (PDF) |
| 224 | PKCβII modulation of myocyte contractile performance | 3.8 | 14 | Citations (PDF) |
| 225 | The Fourth INTERMACS Annual Report: 4,000 implants and counting | 1.1 | 380 | Citations (PDF) |
| 226 | Transplant Registrants With Implanted Left Ventricular Assist Devices Have Insufficient Risk to Justify Elective Organ Procurement and Transplantation Network Status 1A Time | 2.3 | 65 | Citations (PDF) |
| 227 | Delayed sternal closure does not increase late infection risk in patients undergoing left ventricular assist device implantation | 1.1 | 49 | Citations (PDF) |
| 228 | Left Ventricular Assist Device–Associated Infections | 3.1 | 68 | Citations (PDF) |
| 229 | There is plenty for everyone: Transection of the infracardiac inferior vena cava during organ recovery#* | 2.5 | 2 | Citations (PDF) |
| 230 | A Call for Guidance in the Use of Left Ventricular Assist Devices in Older Adults | 2.9 | 26 | Citations (PDF) |
| 231 | Results of the Post-U.S. Food and Drug Administration-Approval Study With a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart Transplantation | 2.3 | 461 | Citations (PDF) |
| 232 | Third INTERMACS Annual Report: The evolution of destination therapy in the United States | 1.1 | 326 | Citations (PDF) |
| 233 | The effectiveness of United Network of Organ Sharing status 2 transplantation in the modern era | 1.1 | 7 | Citations (PDF) |
| 234 | Survival after biventricular assist device implantation: An analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database | 1.1 | 120 | Citations (PDF) |
| 235 | Left ventricular assist device management in patients chronically supported for advanced heart failure | 1.6 | 16 | Citations (PDF) |
| 236 | Continuous Flow Left Ventricular Assist Device Outcomes in Commercial Use Compared With the Prior Clinical Trial | 2.3 | 97 | Citations (PDF) |
| 237 | Endoscopic Findings and Clinical Outcomes in Ventricular Assist Device Recipients with Gastrointestinal Bleeding | 2.1 | 32 | Citations (PDF) |
| 238 | Opportunistic Infections in Heart Transplant Patients | 0.2 | 1 | Citations (PDF) |
| 239 | Diagnosis and Management of Right-Sided Heart Failure in Subjects Supported With Left Ventricular Assist Devices | 0.5 | 30 | Citations (PDF) |
| 240 | Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes | 2.6 | 924 | Citations (PDF) |
| 241 | Post–cardiac transplant survival after support with a continuous-flow left ventricular assist device: Impact of duration of left ventricular assist device support and other variables | 2.6 | 170 | Citations (PDF) |
| 242 | Simultaneous Use of Implantable Cardioverter-Defibrillators and Left Ventricular Assist Devices in Patients With Severe Heart Failure | 1.8 | 53 | Citations (PDF) |
| 243 | Bridge to Transplantation: Current Outcomes | 0.9 | 21 | Citations (PDF) |
| 244 | Successful treatment of pulmonary zygomycosis in two transplant recipients with liposomal amphotericin B and partial surgical resection followed by posaconazole | 3.2 | 9 | Citations (PDF) |
| 245 | Model for End-Stage Liver Disease Score Predicts Left Ventricular Assist Device Operative Transfusion Requirements, Morbidity, and Mortality | 18.0 | 202 | Citations (PDF) |
| 246 | ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant | 18.0 | 24 | Citations (PDF) |
| 247 | The Development of Aortic Insufficiency in Left Ventricular Assist Device-Supported Patients | 4.4 | 368 | Citations (PDF) |
| 248 | Ubiquitin Proteasome Dysfunction in Human Hypertrophic and Dilated Cardiomyopathies | 18.0 | 255 | Citations (PDF) |
| 249 | Continuous Flow Left Ventricular Assist Device Improves Functional Capacity and Quality of Life of Advanced Heart Failure Patients | 2.3 | 566 | Citations (PDF) |
| 250 | ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant | 2.3 | 73 | Citations (PDF) |
| 251 | Clinical management of continuous-flow left ventricular assist devices in advanced heart failure | 1.1 | 838 | Citations (PDF) |
| 252 | Renal and Hepatic Function Improve in Advanced Heart Failure Patients During Continuous-Flow Support With the HeartMate II Left Ventricular Assist Device | 18.0 | 193 | Citations (PDF) |
| 253 | Low Operative Mortality With Implantation of a Continuous-Flow Left Ventricular Assist Device and Impact of Concurrent Cardiac Procedures | 18.0 | 94 | Citations (PDF) |
| 254 | Novel Treatment Options for Chronic Heart Failure: A Radiologist's Perspective | 4.1 | 3 | Citations (PDF) |
| 255 | Percutaneous closure of an iatrogenic atrial septal defect | 1.7 | 12 | Citations (PDF) |
| 256 | Fungemia Associated with Left Ventricular Assist Device Support | 0.9 | 51 | Citations (PDF) |
| 257 | INTERMACS Profiles of Advanced Heart Failure: The Current Picture | 1.1 | 754 | Citations (PDF) |
| 258 | Low Thromboembolism and Pump Thrombosis With the HeartMate II Left Ventricular Assist Device: Analysis of Outpatient Anti-coagulation | 1.1 | 300 | Citations (PDF) |
| 259 | Invited Commentary | 2.3 | 0 | Citations (PDF) |
| 260 | Extended Mechanical Circulatory Support With a Continuous-Flow Rotary Left Ventricular Assist Device | 2.3 | 857 | Citations (PDF) |
| 261 | Short- and Long-Term Survival of Patients Transferred to a Tertiary Care Center on Temporary Extracorporeal Circulatory Support | 2.3 | 31 | Citations (PDF) |
| 262 | Heart and Lung Transplantation in the United States, 1997–2006 | 4.5 | 61 | Citations (PDF) |
| 263 | Advanced Heart Failure: A Call to Action | 2.2 | 51 | Citations (PDF) |
| 264 | The Right Ventricular Failure Risk Score | 2.3 | 743 | Citations (PDF) |
| 265 | INTERMACS Database for Durable Devices for Circulatory Support: First Annual Report | 1.1 | 344 | Citations (PDF) |
| 266 | Left Thoracotomy for Multiple-Time Redo Mitral Valve Surgery Using On-Pump Beating Heart Technique | 2.3 | 27 | Citations (PDF) |
| 267 | Continuous-Flow Rotary Left Ventricular Assist Devices with “3rd Generation” Design | 1.6 | 100 | Citations (PDF) |
| 268 | Sex and Age Dimorphism of Myocardial Gene Expression in Nonischemic Human Heart Failure | 3.8 | 51 | Citations (PDF) |
| 269 | Hemodynamic and Exercise Performance With Pulsatile and Continuous-Flow Left Ventricular Assist Devices | 18.0 | 132 | Citations (PDF) |
| 270 | Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation | 34.5 | 1,682 | Citations (PDF) |
| 271 | Cardiac Improvement During Mechanical Circulatory Support | 18.0 | 402 | Citations (PDF) |
| 272 | Identification of Device Malfunction in Patients Supported With the HeartMate XVE Left Ventricular Assist System | 1.8 | 8 | Citations (PDF) |
| 273 | Improved Mechanical Reliability of the HeartMate XVE Left Ventricular Assist System | 2.3 | 55 | Citations (PDF) |
| 274 | Feasibility and Safety of Autologous Myoblast Transplantation in Patients with Ischemic Cardiomyopathy | 2.7 | 96 | Citations (PDF) |
| 275 | Cardiac Pseudosarcomatous Fibromyxoid Tumor | 1.0 | 12 | Citations (PDF) |
| 276 | Multicenter Experience: Prevention and Management of Left Ventricular Assist Device Infections | 1.8 | 111 | Citations (PDF) |
| 277 | Safety and Feasibility of Autologous Myoblast Transplantation in Patients With Ischemic Cardiomyopathy | 18.0 | 330 | Citations (PDF) |
| 278 | Effect of Oral Vitamin E and C Therapy on Calcineurin Inhibitor Levels in Heart Transplant Recipients | 1.1 | 21 | Citations (PDF) |
| 279 | Nutrition Assessment and Management of Left Ventricular Assist Device Patients | 1.1 | 104 | Citations (PDF) |
| 280 | Anterior Leaflet Repair With Patch Augmentation for Mitral Regurgitation | 2.3 | 39 | Citations (PDF) |
| 281 | Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction | 2.3 | 670 | Citations (PDF) |
| 282 | HeartMate® VE LVAS design enhancements and its impact on device reliability1 | 1.4 | 88 | Citations (PDF) |
| 283 | Infection in permanent circulatory support: Experience from the REMATCH trial | 1.1 | 195 | Citations (PDF) |
| 284 | Atrial reduction plasty Cox maze procedure: extended indications for atrial fibrillation surgery | 2.3 | 59 | Citations (PDF) |
| 285 | INVITED COMMENTARY | 2.3 | 0 | Citations (PDF) |
| 286 | Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans | 2.3 | 472 | Citations (PDF) |
| 287 | Successful treatment of vancomycin resistant enterococcus faecium mediastinitis associated with left ventricular assist devices | 2.3 | 11 | Citations (PDF) |
| 288 | Extracorporeal mechanical circulatory assist | 1.5 | 6 | Citations (PDF) |
| 289 | Myocardial Proinflammatory Cytokine Expression and Left Ventricular Remodeling in Patients With Chronic Mitral Regurgitation | 18.0 | 76 | Citations (PDF) |
| 290 | Nosocomial Infections in Left Ventricular Assist Device Recipients | 5.2 | 87 | Citations (PDF) |
| 291 | Left ventricular assist device therapy improves utilization of donor hearts | 2.3 | 125 | Citations (PDF) |
| 292 | Influence of age on outcomes in patients undergoing mitral valve replacement | 2.3 | 117 | Citations (PDF) |
| 293 | Safety and efficacy of atorvastatin in heart transplant recipients | 1.1 | 32 | Citations (PDF) |
| 294 | LVAD therapy: the future is upon us | 0.0 | 1 | Citations (PDF) |
| 295 | Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival | 1.1 | 62 | Citations (PDF) |
| 296 | Surgical alternatives for heart failure | 1.1 | 59 | Citations (PDF) |
| 297 | Discussion of acute heart failure | 2.3 | 30 | Citations (PDF) |
| 298 | Prophylactic mitral reconstruction for mitral regurgitation | 2.3 | 26 | Citations (PDF) |
| 299 | Effect of postoperative atrial fibrillation on length of stay after cardiac surgery (the postoperative atrial fibrillation in cardiac surgery study [PACS2]) | 1.8 | 73 | Citations (PDF) |
| 300 | Mitral valve repair in heart failure | 7.3 | 41 | Citations (PDF) |
| 301 | Circulatory Assist Devices 2000: An Update | 2.2 | 2 | Citations (PDF) |
| 302 | Assessment of an extracorporeal life support to LVAD bridge to heart transplant strategy | 2.3 | 56 | Citations (PDF) |
| 303 | Intermediate-Term Outcome Of Mitral Reconstruction In Cardiomyopathy | 2.6 | 633 | Citations (PDF) |
| 304 | Preoperative Amiodarone as Prophylaxis against Atrial Fibrillation after Heart Surgery | 34.5 | 529 | Citations (PDF) |
| 305 | Mitral valve reconstruction in sickle cell disease | 2.3 | 22 | Citations (PDF) |
| 306 | The management of tetralogy of fallot with pulmonary atresia and diminutive pulmonary arteries | 2.6 | 51 | Citations (PDF) |
| 307 | Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. | 10.6 | 264 | Citations (PDF) |
| 308 | Medullary parasympathetic projections innervate specific sites in the feline stomach | 0.9 | 36 | Citations (PDF) |
| 309 | Respiratory and cardiovascular effects of intraventricular cholecystokinin | 4.3 | 19 | Citations (PDF) |
| 310 | A Statewide Quality Initiative to Promote Aortic Annular Enlargement: Leading an Evolving Paradigm Shift | 2.3 | 4 | Citations (PDF) |
| 311 | Developing a Toolkit to Reduce Infections Following Durable LVAD Implantation in the United States Using a Multistage Mixed Methods Design | 4.1 | 0 | Citations (PDF) |
| 312 | Mineralocorticoid Receptor Antagonism Reduces Atrial Arrhythmias Post‐Cardiac Surgery and Attenuates Atrial Stress Responses to Cardioplegic Arrest | 4.0 | 3 | Citations (PDF) |
| 313 | Control centers in the central nervous system for regulating gastrointestinal motility | 0.1 | 0 | Citations (PDF) |
| 314 | Clinical Frailty Scale Assessment Before Cardiac Surgery | 2.3 | 3 | Citations (PDF) |
| 315 | Association Between Cardiac Rehabilitation and 1-Year Mortality by Frailty Level in Medicare Beneficiaries | 4.1 | 2 | Citations (PDF) |
| 316 | Metabolic vulnerability and opportunity in donation after circulatory death heart transplantation: Oxygen extraction ratio as a physiologic bridge between donor injury and recipient outcomes | 1.1 | 0 | Citations (PDF) |
| 317 | Algorithm to reduce inter-rater variability in assessment of intermacs patient profiles | 1.1 | 1 | Citations (PDF) |
| 318 | The association between the Distressed Communities Index and failure to rescue after cardiac surgery among Medicare beneficiaries | 2.6 | 1 | Citations (PDF) |
| 319 | Survival After Left Ventricular Assist Device: A Society of Thoracic Surgeons National Intermacs Database Risk Model Assessment | 2.3 | 1 | Citations (PDF) |
| 320 | Rethinking Lifelong Management of Heart Failure Care in Young Adults | 4.4 | 0 | Citations (PDF) |
| 321 | REPLY | 4.4 | 0 | Citations (PDF) |
